Other News

FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia

PASADENA, Calif., April 11, 2019 /PRNewswire/ — Today, the FH Foundation announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal is to accelerate the diagnosis of this life-threatening condition. HoFH is a more severe form of familial hypercholesterolemia (FH), that can lead to heart […]

Stryker Launches LIFEPAK® CR2 Defibrillator with LIFELINKcentral™ AED Program Manager in the United States

REDMOND, Wash., USA, April 11, 2019 /PRNewswire/ — Stryker has launched the company’s newest defibrillation solution, the LIFEPAK® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States. The company has announced that the LIFEPAK CR2 automated external defibrillator (AED) has received Premarket Approval (PMA) by FDA. The LIFPAK CR2 AED was previously released […]

Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders

SAN DIEGO & SAN FRANCISCO–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting. iRhythm is a digital healthcare company that provides ambulatory electrocardiogram monitoring […]

Reflow Medical Announces Enrollment Completion in the Wing-IT IDE CTO Clinical Trial

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. has announced the completion of enrollment in its Wing-ITinvestigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the ability of the Wingman catheter to cross chronic total occlusions (CTOs) in peripheral lesions after failed guidewire attempts. Eighty-five patients with advanced peripheral artery disease enrolled in […]

Aziyo Announces Publication of RECON Study of Pericardial Reconstruction Using ProxiCor

SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo® Biologics, Inc., a fully integrated regenerative medicine company, today announced the publication of results from its landmark RECON study in the Journal of Cardiothoracic Surgery1. The prospective, single arm study included 1,420 patients in 42 hospitals across the United States and represents the largest pericardial-closure study conducted to date. […]

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

LAKE OSWEGO, Ore., April 10, 2019 /PRNewswire/ — BIOTRONIK today announced the United States (US) commercial launch of the PK Papyrus® covered coronary stent system for use in the emergency treatment of acute coronary perforations.1,2 More than 800,000 percutaneous coronary intervention procedures are performed annually in the US3 and fewer than 8,000 require a covered stent, classifying PK […]

Fist Assist Devices, LLC Announces Approval of FACT by University of Chicago Medical Center

LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device startup based in Silicon Valley, Calif., today announced the approval of FACT (Fist Assist Clinical Trial) by the University of Chicago Medical Center Institutional Review Board (IRB). This research will evaluate the effects of using the Fist Assist® device to […]

Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

CALGARY, Alberta, April 09, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment milestone in its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”). Enrollment rates have increased substantially over the past […]

Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role

LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Carol Murdock as Chief Commercial Officer. She will lead Business Development, Account Management, Marketing and Corporate Communications, reporting to Mr. Terren Peizer, Chairman and CEO. Ms. Murdock joins the […]